
PREVALENCE OF RISK FACTORS AND COMORBID CONDITIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
Author(s) -
Abhishek Jain,
Lalit Singh,
Anurag Agrawal,
R. N. Tandon,
Nipun Agrawal
Publication year - 2022
Publication title -
srms journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2456-1673
pISSN - 2455-9652
DOI - 10.21761/jms.v2i01.11206
Subject(s) - medicine , copd , spirometry , diabetes mellitus , obstructive sleep apnea , anthropometry , physical therapy , pediatrics , asthma , endocrinology
COPD is associated with several risk factors and co morbid conditions. Dealing
with co-morbidity needs a patient centered approach, rather than a disease oriented approach7.
The present study was conducted to study risk factors and co morbid conditions of COPD
patients.
Material and Methods: The present study was conducted in department of Pulmonary
Medicine at Shri Ram Murti Smarak Institute of Medical Sciences with respiratory complaints
over a period of one and a half year. The data was collected in terms of demographic features,
anthropometric measurements and various risk factors and co morbid conditions. Spirometry
was performed thrice and the largest values of both FVC and FEV1 were noted from three
technically satisfactory curves. COPD severity was classified based on Spirometric
assessment according to the GOLD classification. Categorical variables were analyzed using
proportions and percentages.
Results: In a study of 201 cases that were diagnosed as a case of COPD the mean age was 62.6
years and male predominance. Majority of the patients had sedentary life style and were from
poor class. The co morbid conditions anemia, cardiac, hypertension, diabetes mellitus, lipid
disorders, thyroid disorders, osteoporosis, psychiatric illness, ophthalmic defects and
obstructive sleep apnea was found in 43.8%, 52.2%, 65.2%, 52.2%, 51.7%, 64.7%, 72.1%,
66.7%, 28.9% and 54.2% respectively.
Conclusion: Co morbidities should be taken into consideration while prescribing multiple
drugs so that side effects and interactions of drug can be monitored and quality of life can be
improved.